Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 737

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

Li, Xiaoguang, Yao, Wenbo, Yuan, Ya, Chen, Peizhan, Li, Bin, Li, Jingquan, Chu, Ruiai, Song, Haiyun, Xie, Dong, Jiang, Xiaoqing, Wang, Hui·2017·Gut

Abstract

Objective: Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective treatment options. An alternative strategy is to target cells, such as tumour-infiltrating macrophages, in the HCC tumour microenvironment. The CCL2/CCR2 axis is required for recruitment of monocytes/macrophages and is implicated in various aspects of liver pathology, including HCC. We investigated the feasibility of CCL2/CCR2 as a therapeutic target against HCC. Design: CCL2 expression was analysed in two independent HCC cohorts. Growth of three murine HCC cells was evaluated in an orthotopic model, a postsurgical recurrence model and a subcutaneous model in mice after blocking CCL2/CCR2 axis by a novel CCR2 antagonist or knocking out of host CCR2. In vivo macrophage or T cell depletion and in vitro cell coculture were further conducted to investigate CCL2/CCR2-mediated crosstalk between tumour-associated macrophages (TAMs) and tumour cells. Result: CCL2 is overexpressed in human liver cancers and is prognostic for patients with HCC. Blockade of CCL2/CCR2 signalling with knockout of CCR2 or with a CCR2 antagonist inhibits malignant growth and metastasis, reduces postsurgical recurrence, and enhances survival. Further, therapeutic blocking of the CCL2/CCR2 axis inhibits the recruitment of inflammatory monocytes, infiltration and M2-polarisation of TAMs, resulting in reversal of the immunosuppression status of the tumour microenvironment and activation of an antitumorous CD8 + T cell response. Conclusions: In patients with liver cancer, CCL2 is highly expressed and is a prognostic factor. Blockade of CCL2/CCR2 signalling suppresses murine liver tumour growth via activating T cell antitumour immune response. The results demonstrate the translational potential of CCL2/CCR2 blockade for treatment of HCCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2015-310514

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 40

  1. 10.3322/caac.20107 · DOI · Paper page
  2. Ryder, 2003, Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults, Gut, 52, iii1
  3. 10.1038/nrc1782 · DOI · Paper page
  4. 10.1126/science.1232227 · DOI · Paper page
  5. 10.1016/j.cell.2010.03.014 · DOI · Paper page
  6. 10.1007/s00595-011-0058-8 · DOI · Paper page
  7. 10.1016/j.humpath.2008.08.011 · DOI · Paper page
  8. 10.1016/j.coi.2010.01.009 · DOI · Paper page
  9. 10.1159/000012021 · DOI · Paper page
  10. 10.1002/emmm.201202367 · DOI · Paper page
  11. 10.1126/science.1178331 · DOI · Paper page
  12. 10.1038/ni1309 · DOI · Paper page
  13. 10.1038/nrc3078 · DOI · Paper page
  14. 10.1002/hep.24599 · DOI · Paper page
  15. 10.1136/gutjnl-2011-300304 · DOI · Paper page
  16. 10.4049/jimmunol.1302821 · DOI · Paper page
  17. 10.1016/B978-0-12-385071-3.00003-4 · DOI
  18. 10.1093/jnci/djq044 · DOI · Paper page
  19. 10.1007/s10637-012-9869-8 · DOI · Paper page
  20. 10.1093/jnci/64.4.809 · DOI
  21. 10.1371/journal.pone.0028405 · DOI
  22. 10.1038/nrd2734 · DOI · Paper page
  23. 10.1097/01.sla.0000197706.21803.a1 · DOI · Paper page
  24. 10.1038/nrc1256 · DOI · Paper page
  25. 10.1007/s12307-011-0091-6 · DOI
  26. Mizgerd, 1996, Gadolinium induces macrophage apoptosis, J Leukoc Biol, 59, 189, 10.1002/jlb.59.2.189 · DOI
  27. 10.1002/hep.510290324 · doi:10.1002/hep.510290324
  28. 10.1016/j.it.2011.12.001 · DOI · Paper page
  29. 10.1002/hep.23711 · DOI
  30. 10.1038/nrgastro.2010.221 · doi:10.1038/nrgastro.2010.221
  31. 10.2174/157488708783330549 · DOI
  32. 10.1200/JCO.2013.49.5622 · doi:10.1200/jco.2013.49.5622
  33. 10.4049/jimmunol.0802793 · DOI
  34. 10.1158/0008-5472.CAN-11-1792 · DOI · Paper page
  35. 10.1126/science.aaa8172 · DOI · Paper page
  36. 10.1016/j.jhep.2013.06.008 · DOI
  37. Capece, 2013, The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages, Biomed Res Int, 2013, 187204, 10.1155/2013/187204 · DOI · Paper page
  38. 10.1111/imm.12023 · DOI · Paper page
  39. 10.1038/nature13862 · DOI · Paper page
  40. 10.1038/nrgastro.2010.100 · DOI · Paper page

Cited by

See all 737

Metadata

Authors
Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., & Wang, H.
Venue
Gut
Publisher
BMJ
Published
2015-10-09
Volume
66
Issue
1
Pages
157-167
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2098236252
Cited by
737
References
7
FWCI
11.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. https://app.cochat.ai/papers/10.1136/gutjnl-2015-310514
The paper
Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., & Wang, H. (2017). Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. https://doi.org/10.1136/gutjnl-2015-310514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.